Kentucky · 2025 Regular Session · Bill
HB 384: AN ACT relating to intranasal epinephrine.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 384 is a bill introduced in the Kentucky House on February 6, 2025. According to its official title, it concerns: AN ACT relating to intranasal epinephrine. Most recent recorded action (February 12, 2025): to Health Services (H).
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Amend KRS 158.832 to include intranasal epinephrine to list of medications used to treat anaphylaxis; amend KRS 158.836 to include intranasal epinephrine as permissible for schools to keep.
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| No sponsor recorded in source data. | ||||
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- to Health Services (H)
- to Committee on Committees (H)
- introduced in House